Brief: Lonza H1 Sales CHF 3,600 Million Vs. IBES Estimate CHF 3,464 Million
Jul 23 (Reuters) - Lonza H1 CORE EBITDA CHF 1,100 million vs. IBES estimate CHF 973.2 million.
Recent news on Lonza AG
See all newsLonza buys 5 sites from Germany's Merck to more than double US footprint (updated)
Brief: Merck KGaA Confirms Divestment Of CDMO Business To Lonza
Lonza agrees to buy five US sites from Merck KGaA
Corrected: TABLE-Swiss trade surplus at CHF 4.35 bln in August (Sept. 17)
Table: Swiss trade surplus at CHF 1.31 bln in September